← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-03-03

Drug application

FDA Application #

ANDA077221

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

First approval

2017-03-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown